Tamás Oravecz
Ribon Therapeutics (United States)(US)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Microtubule and mitosis dynamics, Cancer Treatment and Pharmacology, Immune Cell Function and Interaction, HIV Research and Treatment
Most-Cited Works
- → Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage(1997)337 cited
- → A mouse knockout library for secreted and transmembrane proteins(2010)334 cited
- → Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses(2006)332 cited
- → Cell-Surface Heparan Sulfate Proteoglycan Mediates HIV-1 Infection of T-Cell Lines(1993)250 cited
- → Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization(1994)238 cited
- → Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41(1995)236 cited
- → Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine(2013)191 cited
- → Ablation of Ribosomal Protein L22 Selectively Impairs αβ T Cell Development by Activation of a p53-Dependent Checkpoint(2007)169 cited
- → Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions(2008)158 cited
- → Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B(2012)153 cited